{
    "ticker": "ARCT",
    "name": "Arcturus Therapeutics Holdings Inc.",
    "description": "Arcturus Therapeutics Holdings Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative RNA medicines. Founded in 2013, the company is dedicated to advancing the fields of mRNA therapeutics and vaccines, with a goal of addressing unmet medical needs in various therapeutic areas including infectious diseases, rare diseases, and cancer. Arcturus leverages its proprietary LUNAR delivery technology to enhance the delivery and efficacy of RNA-based therapeutics. The company gained significant attention for its work on a COVID-19 vaccine, which incorporates its mRNA technology. Arcturus is also developing treatments for liver diseases and other serious conditions. With a strong pipeline of candidates in clinical and preclinical development, Arcturus aims to transform the landscape of medicine by harnessing the potential of RNA to create safer and more effective therapies. The company's commitment to innovation is reflected in its collaborative partnerships with leading research institutions and pharmaceutical companies to advance its research and development efforts.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2013",
    "website": "https://www.arcturustx.com",
    "ceo": "Joseph Payne",
    "social_media": {
        "twitter": "https://twitter.com/arcturustx",
        "linkedin": "https://www.linkedin.com/company/arcturus-therapeutics/"
    },
    "investor_relations": "https://investors.arcturustx.com",
    "key_executives": [
        {
            "name": "Joseph Payne",
            "position": "CEO"
        },
        {
            "name": "Chad K. M. Dyer",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "RNA Therapeutics",
            "products": [
                "COVID-19 Vaccine",
                "Liver Disease Treatments"
            ]
        }
    ],
    "seo": {
        "meta_title": "Arcturus Therapeutics | Innovative RNA Medicines",
        "meta_description": "Learn about Arcturus Therapeutics Holdings Inc., a leader in RNA medicine development, focusing on vaccines and therapeutics for various diseases.",
        "keywords": [
            "Arcturus Therapeutics",
            "RNA Medicines",
            "COVID-19 Vaccine",
            "Biotechnology",
            "Pharmaceuticals"
        ]
    },
    "faq": [
        {
            "question": "What does Arcturus Therapeutics specialize in?",
            "answer": "Arcturus Therapeutics specializes in the development of RNA medicines and vaccines."
        },
        {
            "question": "Who is the CEO of Arcturus Therapeutics?",
            "answer": "Joseph Payne is the CEO of Arcturus Therapeutics Holdings Inc."
        },
        {
            "question": "Where is Arcturus headquartered?",
            "answer": "Arcturus is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are some of the products in development by Arcturus?",
            "answer": "Arcturus is developing an RNA-based COVID-19 vaccine and treatments for liver diseases."
        },
        {
            "question": "When was Arcturus Therapeutics founded?",
            "answer": "Arcturus Therapeutics was founded in 2013."
        }
    ],
    "competitors": [
        "MRNA",
        "PFE",
        "NVAX",
        "BNTX"
    ],
    "related_stocks": [
        "GILD",
        "AMGN",
        "REGN",
        "VRTX"
    ]
}